RT Journal Article
T1 Bibliometric analysis of global sickle cell disease research from 1997 to 2017
A1 Uchechi Okoroiwu, Henshaw
A1 López Muñoz, Francisco
A1 Povedano Montero, Francisco Javier
AB IntroductionSickle cell disease is an autosomal recessive genetic disease caused by a single point mutation in the β-globin chain of the hemoglobin. It has been recognized by the World Health Organization as a public health priority since 2006.MethodsThe Scopus database was used in this study with the search descriptors: “sickle cell” and “sickle cell disease”. We applied common bibliometric indicators to evaluate the trend in scientific literature in sickle cell disease research.ResultsWe retrieved a total of 19,921 pieces of scientific literature in the repertoire from 1997 to 2017. The Price law was fulfilled in the trend of production of scientific literature on SCD as the growth of scientific literature was more exponential (r = 0.9751; r2 = 0.9509) than linear (r = 0.9721; r2 = 0.9449). We observed a duplication time of 4.52 years. The Bradford core was made up of 69 journals with Blood at the top, publishing the greatest number of articles. The most productive institutions were mostly United States agencies and hospitals. The United States was the most productive country. The National Institute of Health was the most productive institution and also had the highest number of citations. Vichinsky E was the most productive author, while the most cited article was published by Circulation.ConclusionThe growth of scientific literature in Sickle cell disease was found to be high. However, the exponential growth trend shows a “yet-to-be-explored” area of research. This study will be useful for physicians, researchers, research funders and policy-cum-decision makers.
PB Elsevier
SN 2531-1379
YR 2022
FD 2022-05-13
LK https://hdl.handle.net/20.500.14352/91827
UL https://hdl.handle.net/20.500.14352/91827
LA eng
NO Uchechi Okoroiwu, Henshaw, López Muñoz , Francisco, Povedano Montero, Francisco Javier. Bibliometric analysis of global sickle cell disease research from 1997 to 2017. Hematology, Transfusion and Cell Therapy. 2022; 44(2):186-196
DS Docta Complutense
RD 6 abr 2025